| Date Filed | Type | Description |
| 02/05/2015 |
SC 13G/A
| MPM BIOVENTURES II QP LP reports a |
| 02/12/2014 |
SC 13G
| MPM BIOVENTURES II QP LP reports a 7.1% stake in Macrogenics, Inc. |
| 02/12/2014 |
SC 13G/A
| MPM BIOVENTURES II QP LP reports a 2.7% stake in AVEO PHARMACEUTICALS, INC. |
| 02/07/2013 |
SC 13G/A
| MPM BIOVENTURES II QP LP reports a 5.1% stake in AVEO PHARMACEUTICALS, INC. |
| 02/09/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/04/2008 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 06/29/2007 |
SC 13D
| MPM BIOVENTURES II QP LP has filed a Schedule 13D for ALSIUS CORPORATION |
| 06/14/2007 |
SC 13D/A
| MPM BIOVENTURES II QP LP has filed a Schedule 13D for CRITICAL THERAPEUTICS, INC. |
| 05/22/2007 |
SC 13D/A
| MPM BIOVENTURES II QP LP has filed a Schedule 13D for CRITICAL THERAPEUTICS, INC. |
| 05/02/2007 |
SC 13D
| MPM BIOVENTURES II QP LP has filed a Schedule 13D for CRYOCOR, INC. |
| 02/21/2007 |
SC 13D/A
| MPM BIOVENTURES II QP LP has filed a Schedule 13D for CRITICAL THERAPEUTICS, INC. |
| 02/12/2007 |
SC 13G
| MPM BIOVENTURES II QP LP reports a |
| 02/13/2006 |
SC 13G
| MPM BIOVENTURES II QP LP reports a |
| 02/13/2006 |
SC 13G
| MPM BIOVENTURES II QP LP reports a |
| 02/13/2006 |
SC 13D
| MPM BIOVENTURES II QP LP has filed a Schedule 13D for CRITICAL THERAPEUTICS, INC. |
| 02/13/2006 |
SC 13D
| MPM BIOVENTURES II QP LP has filed a Schedule 13D for METABASIS THERAPEUTICS, INC. |
| 02/13/2006 |
SC 13G/A
| MPM BIOVENTURES II QP LP reports a 0% stake in XCYTE THERAPIES, INC. |